Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 9 min ago

Oncology

5,176 studies502 in 7 days2,477 in 30 days

Filters
Type
Date
Clear

Latest

5,176 studies

  1. Survival factors in lung cancer patients with mutations in the PROS1, SERPINC1, F2, and F5 genes.
    Ryan Brownlee, Aditya Birla, Hung Bui +4
    OncotargetPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  2. Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS-STING-STAT3 survival axis.
    Jiagui Song, Zhengyang Guo, Decao Yang +8
    Clinical and translational medicinePeer-reviewedCC BYFull textOncologyEurope PMCPMC
  3. Baseline Peripheral Neuropathy Predicts Clinically Significant Neuropathy During Paclitaxel Treatment Following Oxaliplatin-based Chemotherapy.
    Aiko Tomiuchi, Michio Kimura, Yoshiaki Ikeda +1
    Cancer diagnosis & prognosisPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  4. Larger Non-metastatic No. 8 Lymph Node Size Is Associated With Favorable Prognosis After Pancreaticoduodenectomy for Pancreatic Cancer.
    Taro Sakamoto, Takeshi Gocho, Masashi Tsunematsu +10
    Cancer diagnosis & prognosisPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  5. Optimal Exercise Dose for Improving Multidimensional Health Outcomes in Colorectal Cancer Patients: A Systematic Review, Meta-Analysis and Meta-Regression.
    Jingyu Wang, Yuxuan He, Zhouluo Wang +8
    European journal of sport sciencePeer-reviewedCC BYFull textOncologyEurope PMCPMC
  6. Mechanisms of Tumor Cell Invasion: Insights From the Perspective of Epithelial-to-Mesenchymal Transition.
    Marcello Guarino
    Cell biochemistry and functionPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  7. Baseline Spleen Volume is Independently Associated With Survival After CD19-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma.
    Lucas Brehm, Philipp Schindler, Christian Römer +11
    Hematological oncologyPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  8. c-MET Inhibition Is Accompanied by PD-L1 Upregulation and Immunosuppression-Related Tumor Microenvironment Changes in Esophageal Squamous Cell Carcinoma, With Enhanced Antitumor Activity in Combination With Anti-PD-1 Therapy.
    Chuan Song, Zhe Xia, Hu Wang +5
    Cancer medicinePeer-reviewedCC BY-NCFull textOncologyEurope PMCPMC
  9. Cost-Effectiveness of Colorectal Cancer Screening Tests: Reply to Response.
    Chris Estes, Paul J Limburg
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  10. Prognostic Relevance of Surface α-Enolase (ENO1) in Patients With Lung Adenocarcinoma.
    Yu-Sen Lin, Te-Hong Chen, Yuan-Yao Tsai +6
    Cancer diagnosis & prognosisPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  11. Merkel Cell Polyomavirus-Negative Merkel Cell Carcinoma Presenting in the Parotid Gland: Precise Diagnosis and Complete Pathological Response to Nivolumab.
    Arthur Z Li, Daniel I Chung, Shannon M Poti +2
    Cancer diagnosis & prognosisPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  12. Development and Validation of a Gene Expression‐Based Prognostic Model for Patients With Small Cell Lung Cancer Treated With Chemotherapy
    Tingting Liu, Ting Zhou, Silang Mo +16
    MedCommPeer-reviewedCC BYFull textOncologyEurope PMCPMCEurope PMC
  13. Beyond DNA Damage: The Impact of Tobacco Smoke and Its Derivatives on MicroRNAs in Lung Cancer Pathogenesis
    Alina M. Perevalova, Lyudmila F. Gulyaeva, Vladimir O. Pustylnyak
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  14. Quality-of-Life Changes Following Cisplatin-Based Chemotherapy in Patients with Lung Cancer and Cisplatin-Induced Peripheral Neuropathy: A Sex-Stratified Analysis
    Sanja Tomanovic Vujadinovic, Nevena Krstic, Ivan Selakovic +5
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  15. SMARCA4 MUTATIONS PROMOTE CHEMOTHERAPY RESISTANCE IN T-ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH ALTERED CHROMATIN REMODELING AT AP1-ASSOCIATED REGULATORY REGIONS
    V. Garcia-Hernandez, M. Maqueda, G. Faccincani +10
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  16. Structure-Function Analysis of an Infantile Rhabdomyosarcoma Fusion-Oncogene Reveals Domain Requirements for Tumorigenesis
    C. S. Sankhe, D. Calderon, C. Taslim +8
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  17. Endogenous PROM1 activation redistributes liver cancer cells along a preexisting differentiation axis
    T. Schneider, K. Kaneko, M. Vogl +9
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  18. Decoding stress-induced adaptation of cancer cells in spatial confinement by integrating live-cell imaging and mathematical modeling
    G. V. Kulkarni, A. MOHANTY, A. R. Subbalakshmi +7
    bioRxivPreprintCC BYFull textOncologybioRxiv
  19. Enhancing cell type deconvolution in spatial transcriptomics through incorporating multiple reference panels
    Peiyao Zhao, Justin A Colacino, Ying Ma +1
    PLOS GeneticsPeer-reviewedCC BYFull textOncologyPhysiologyPLOSEurope PMCEurope PMCPMC
  20. Nemo-like kinase limits T cell activation while preserving anti-tumor responses
    Sebastian Peer, Jiří Koutník, Nikolaus Thuille +9
    iSciencePeer-reviewedCC BY 4.0OncologyCrossrefCell Press
  21. Oncogenic CLDN1 promotes thyroid cancer progression through TAp63-mediated glycolytic switching
    Bowei Zhang, Jinju Wang, Qianxi Zhang +1
    iSciencePeer-reviewedCC BY 4.0OncologyCrossrefCell Press
  22. Pancreatic cancer in Pakistan: a lens into the research landscape
    Shamsher Ali Pasha, Kaleem Sohail Ahmed, Mabrooka Kazi +2
    Journal of the Pakistan Medical AssociationPeer-reviewedCC BYFull textOncologyDOAJ
  23. Screening mammogram – Assessment of eligible females’ knowledge, attitude and practice, at a tertiary care hospital in Karachi
    Mahrukh Naz, Omema Saleem, Umm e Habiba Abdul Rauf +3
    Journal of the Pakistan Medical AssociationPeer-reviewedCC BYFull textOncologyDOAJ
  24. In situ-activated engineered bacteria release combined dual-therapeutic proteins for tumor immunotherapy
    Xin-Ge Wang, Yue-Lan Huang, Xuan-Ren Shi +3
    iSciencePeer-reviewedCC BY 4.0OncologyCell PressCrossref
  25. Development of an algorithm to support cancer registry registration by identifying patients with metachronous metastases after primary breast cancer
    L. de Munck, H. Buisman, J. Verloop +1
    ESMO Real World Data and Digital OncologyPeer-reviewedCC BY-NC-NDFull textOncologyDOAJ